DUBLIN, Sept. 5, 2023 /PRNewswire/ — The “Global Coagulation Market Analysis & Forecast to 2023-2033: Market Product Type, Test Type, by End-User, and by Region” report has been added to ResearchAndMarkets.com’s offering.
The global coagulation market size was estimated to be USD 4.2 billion in 2023 and is expected to reach at USD 8.1 billion by 2033 with a CAGR of 7.2%.
Increasing incidence of bleeding disorders, rising technological advancements, increasing surgical procedures, growing awareness and diagnosis of coagulation disorders, and increasing research and development activities will drive the market growth.
The accuracy, speed, and efficiency of coagulation testing have all improved as a result of technological and instrument advancements. Faster and more convenient testing has been made possible by the introduction of automated coagulation analyzers and point-of-care testing equipment, which has stimulated market expansion.
By product type, fibrinolytic agents was the highest revenue-grossing segment in the global coagulation market in 2022 owing to their critical role in the management of thrombotic disorders and the increasing adoption of fibrinolytic therapy in various healthcare settings.
Coagulation factors will be the fastest revenue-grossing segment in the global coagulation market in 2022 owing to the growing demand for replacement therapies in patients with inherited bleeding disorders, such as hemophilia, von Willebrand disease, and factor deficiencies.
By test type, prothrombin time (PT) tests was the highest revenue-grossing segment in the global coagulation market in 2022 owing to the widespread use of PT tests in various clinical settings, including hospitals, diagnostic laboratories, and point-of-care settings.
Activated partial thromboplastin time tests will be the fastest revenue-grossing segment in the global coagulation market in 2022 owing to the rising incidence of coagulation disorders, such as hemophilia, lupus anticoagulant, and von Willebrand disease, which necessitate regular monitoring of the intrinsic pathway of the coagulation cascade.
By end-user, hospitals was the highest revenue-grossing segment in the global coagulation market in 2022 owing to the significant volume of coagulation testing conducted in hospital settings and the wide range of coagulation-related procedures performed within these facilities.
Research institutes will be the fastest revenue-grossing segment in the global coagulation market in 2022 owing to the growing focus on research and development activities in the field of coagulation, driving the demand for specialized coagulation testing, innovative therapies, and cutting-edge technologies.
Global Coagulation, By Region (USD Billion)
North America was the highest revenue-grossing segment in the global coagulation market in 2022 owing to the well-established healthcare infrastructure, high prevalence of coagulation disorders, and strong adoption of advanced coagulation testing and management practices.
Asia Pacific will be the fastest revenue-grossing segment in the global coagulation market in 2022 owing to the increasing prevalence of coagulation disorders, improving healthcare infrastructure, and a growing focus on early diagnosis and treatment.
Key Attributes:
|
Report Attribute |
Details |
|
No. of Pages |
145 |
|
Forecast Period |
2022 – 2033 |
|
Estimated Market Value (USD) in 2022 |
$4.2 Billion |
|
Forecasted Market Value (USD) by 2033 |
$8 Billion |
|
Compound Annual Growth Rate |
6.0 % |
|
Regions Covered |
Global |
Company Profiles
- CryoLife, Inc
- Baxter International, Inc
- Cohera Medical, Inc
- C.R. Bard, Inc
- Ethicon, Inc. [J&J]
- Cardinal Health
- Integra LifeSciences Holdings Corporation
- Mallinckrodt plc
- B. Braun Melsungen AG
Report Scope:
- Base Year: 2022
- Forecast Period: 2023-2033
- Study Coverage
- Market Forecast by Product type, Test type, End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: Coagulation Market Report 2022-2033
Coagulation Market Analysis & Forecast by Product Type 2022-2033 (Revenue USD Bn)
- Coagulation Analyzers
- Consumables
- Coagulation Factors
- Fibrinolytic Agents
Coagulation Market Analysis & Forecast by Test Type 2022-2033 (Revenue USD Bn)
- Prothrombin Time (PT) Tests
- Activated Partial Thromboplastin Time Tests
- D-Dimer Tests
- Platelet Function Tests
Coagulation Market Analysis & Forecast by End-user 2022-2033 (Revenue USD Bn)
- Hospitals
- Diagnostic Laboratories
- Research Institutes
For more information about this report visit https://www.researchandmarkets.com/r/pjtbk4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:SOURCE Research and Markets
Featured image: Megapixl © Adiruch